Search results
Cel Sci exec Patricia Prichep buys $11,120 in company stock By Investing.com
Investing.com· 18 hours agoCel Sci Corporation's (AMEX:CVM) Senior Vice President, Patricia Prichep, has recently purchased...
FDA greenlights CEL-SCI confirmatory study for Multikine By Investing.com
Investing.com· 2 days agoCEL-SCI Corporation (NYSE American: CVM) announced today that the U.S. Food and Drug Administration...
Nine in 10 U.S. adults have syndrome that leads to heart disease
United Press International via Yahoo News· 2 days agoNine of 10 American adults are in the early, middle or late stages of a syndrome that leads to heart...
Registration Now Open for 'A Different Way to CE!'
KTLA-TV Los Angeles· 7 days agoLANCASTER, S.C., May 3, 2024 /PRNewswire/ -- 'A Different Way to CE' is back for the fourth year in Nashville, Tennessee! Attendees will enjoy one-of-a-kind fellowship with other veterinary ...
The Brink’s Company (NYSE:BCO) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 19 hours agoThe Brink’s Company (NYSE:BCO) Q1 2024 Earnings Call Transcript May 8, 2024 The Brink’s Company...
Heidi Banse named dean of A-State veterinary school - Talk Business & Politics
Talk Business & Politics· 6 days agoDr. Heidi E. Cox Banse has accepted the role as dean of the forthcoming Arkansas State University...
Experts provide facts about avian influenza for dairy producers
Phys.org· 3 days ago...internal temperatures inactivates the strain of avian influenza, called H5N1, according to...
Head-to-head Superiority to High-dose Dulaglutide: Innovent's First Phase 3 Clinical Trial of...
FOX 23 News Albany· 1 day agoInnovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that...
Crofelemer, Jaguar Health’s Prescription Drug Conditionally Approved by the FDA for...
Digital Journal· 4 days agoDiarrhea is one of the most common reasons for veterinary visits for dogs and the second most common reason for visits to the veterinary emergency room, yet there are currently no FDA-approved ...
